Compare Apartment Investment and Management Co (AIV) vs BridgeBio Pharma Inc (BBIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Apartment Investment and Management Co vs BridgeBio Pharma Inc — how do they compare? Apartment Investment and Management Co trades at $2.61 (market cap $376.16M), while BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B). The key difference: BridgeBio Pharma Inc is far larger — about 43.5× Apartment Investment and Management Co's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Apartment Investment and Management Co nearer its low. Which is the better fit depends on your goals.
| AIV | BBIO | |
|---|---|---|
Market Cap | $376.16M | $16.36B |
Sector | Real Estate | Health |
52-Week High | $7.93 | $90.17 |
52-Week Low | $2.59 | $47.29 |
Enterprise Value | $738.32M | $18.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Apartment Investment and Management Co
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment
Read more on AIV →About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →
